nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2C9—Sorafenib—thyroid cancer	0.122	0.229	CbGbCtD
Dolasetron—CYP3A4—Vandetanib—thyroid cancer	0.117	0.221	CbGbCtD
Dolasetron—CYP2D6—Sorafenib—thyroid cancer	0.111	0.209	CbGbCtD
Dolasetron—CYP3A4—Sorafenib—thyroid cancer	0.0708	0.133	CbGbCtD
Dolasetron—CYP2D6—Doxorubicin—thyroid cancer	0.0675	0.127	CbGbCtD
Dolasetron—CYP3A4—Doxorubicin—thyroid cancer	0.043	0.0808	CbGbCtD
Dolasetron—Stomatitis—Sorafenib—thyroid cancer	0.00269	0.00575	CcSEcCtD
Dolasetron—Jaundice—Sorafenib—thyroid cancer	0.00269	0.00575	CcSEcCtD
Dolasetron—Dry mouth—Vandetanib—thyroid cancer	0.00266	0.00569	CcSEcCtD
Dolasetron—Oedema—Vandetanib—thyroid cancer	0.00261	0.00558	CcSEcCtD
Dolasetron—Epistaxis—Sorafenib—thyroid cancer	0.0026	0.00556	CcSEcCtD
Dolasetron—Thrombocytopenia—Vandetanib—thyroid cancer	0.00256	0.00546	CcSEcCtD
Dolasetron—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.00246	0.00526	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00238	0.00508	CcSEcCtD
Dolasetron—Paraesthesia—Vandetanib—thyroid cancer	0.00234	0.00501	CcSEcCtD
Dolasetron—Dyspnoea—Vandetanib—thyroid cancer	0.00233	0.00497	CcSEcCtD
Dolasetron—Tinnitus—Sorafenib—thyroid cancer	0.00231	0.00494	CcSEcCtD
Dolasetron—Flushing—Sorafenib—thyroid cancer	0.0023	0.00491	CcSEcCtD
Dolasetron—Dyspepsia—Vandetanib—thyroid cancer	0.0023	0.00491	CcSEcCtD
Dolasetron—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.00228	0.00487	CcSEcCtD
Dolasetron—Decreased appetite—Vandetanib—thyroid cancer	0.00227	0.00485	CcSEcCtD
Dolasetron—Fatigue—Vandetanib—thyroid cancer	0.00225	0.00481	CcSEcCtD
Dolasetron—Injection site pain—Epirubicin—thyroid cancer	0.00223	0.00477	CcSEcCtD
Dolasetron—Pain—Vandetanib—thyroid cancer	0.00223	0.00477	CcSEcCtD
Dolasetron—Constipation—Vandetanib—thyroid cancer	0.00223	0.00477	CcSEcCtD
Dolasetron—Arrhythmia—Sorafenib—thyroid cancer	0.00221	0.00473	CcSEcCtD
Dolasetron—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00213	0.00456	CcSEcCtD
Dolasetron—Dysgeusia—Sorafenib—thyroid cancer	0.00211	0.00451	CcSEcCtD
Dolasetron—Injection site pain—Doxorubicin—thyroid cancer	0.00207	0.00442	CcSEcCtD
Dolasetron—Abdominal pain—Vandetanib—thyroid cancer	0.00206	0.00441	CcSEcCtD
Dolasetron—Body temperature increased—Vandetanib—thyroid cancer	0.00206	0.00441	CcSEcCtD
Dolasetron—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.00201	0.00428	CcSEcCtD
Dolasetron—Anaemia—Sorafenib—thyroid cancer	0.00199	0.00426	CcSEcCtD
Dolasetron—Oliguria—Epirubicin—thyroid cancer	0.00198	0.00423	CcSEcCtD
Dolasetron—Angioedema—Sorafenib—thyroid cancer	0.00197	0.00421	CcSEcCtD
Dolasetron—Syncope—Sorafenib—thyroid cancer	0.00194	0.00413	CcSEcCtD
Dolasetron—Loss of consciousness—Sorafenib—thyroid cancer	0.0019	0.00405	CcSEcCtD
Dolasetron—Cough—Sorafenib—thyroid cancer	0.00188	0.00402	CcSEcCtD
Dolasetron—Atrioventricular block—Epirubicin—thyroid cancer	0.00188	0.00402	CcSEcCtD
Dolasetron—Asthenia—Vandetanib—thyroid cancer	0.00187	0.004	CcSEcCtD
Dolasetron—Hypertension—Sorafenib—thyroid cancer	0.00186	0.00398	CcSEcCtD
Dolasetron—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00186	0.00396	CcSEcCtD
Dolasetron—Pruritus—Vandetanib—thyroid cancer	0.00185	0.00394	CcSEcCtD
Dolasetron—Myalgia—Sorafenib—thyroid cancer	0.00184	0.00392	CcSEcCtD
Dolasetron—Arthralgia—Sorafenib—thyroid cancer	0.00184	0.00392	CcSEcCtD
Dolasetron—Oliguria—Doxorubicin—thyroid cancer	0.00183	0.00391	CcSEcCtD
Dolasetron—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00182	0.0039	CcSEcCtD
Dolasetron—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.00182	0.0039	CcSEcCtD
Dolasetron—Hiccups—Epirubicin—thyroid cancer	0.00182	0.0039	CcSEcCtD
Dolasetron—Dry mouth—Sorafenib—thyroid cancer	0.0018	0.00384	CcSEcCtD
Dolasetron—Eructation—Epirubicin—thyroid cancer	0.00179	0.00383	CcSEcCtD
Dolasetron—Diarrhoea—Vandetanib—thyroid cancer	0.00179	0.00382	CcSEcCtD
Dolasetron—Influenza like illness—Epirubicin—thyroid cancer	0.00177	0.00378	CcSEcCtD
Dolasetron—Anaphylactic shock—Sorafenib—thyroid cancer	0.00176	0.00376	CcSEcCtD
Dolasetron—Atrioventricular block—Doxorubicin—thyroid cancer	0.00174	0.00372	CcSEcCtD
Dolasetron—Shock—Sorafenib—thyroid cancer	0.00173	0.0037	CcSEcCtD
Dolasetron—Dizziness—Vandetanib—thyroid cancer	0.00173	0.00369	CcSEcCtD
Dolasetron—Thrombocytopenia—Sorafenib—thyroid cancer	0.00172	0.00368	CcSEcCtD
Dolasetron—Aplastic anaemia—Epirubicin—thyroid cancer	0.00171	0.00366	CcSEcCtD
Dolasetron—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00169	0.00361	CcSEcCtD
Dolasetron—Hiccups—Doxorubicin—thyroid cancer	0.00169	0.00361	CcSEcCtD
Dolasetron—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.00169	0.00361	CcSEcCtD
Dolasetron—Anorexia—Sorafenib—thyroid cancer	0.00168	0.00359	CcSEcCtD
Dolasetron—Eructation—Doxorubicin—thyroid cancer	0.00166	0.00354	CcSEcCtD
Dolasetron—Rash—Vandetanib—thyroid cancer	0.00165	0.00352	CcSEcCtD
Dolasetron—Dermatitis—Vandetanib—thyroid cancer	0.00164	0.00351	CcSEcCtD
Dolasetron—Influenza like illness—Doxorubicin—thyroid cancer	0.00164	0.0035	CcSEcCtD
Dolasetron—Headache—Vandetanib—thyroid cancer	0.00164	0.00349	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.0016	0.00343	CcSEcCtD
Dolasetron—Abnormal vision—Epirubicin—thyroid cancer	0.00159	0.0034	CcSEcCtD
Dolasetron—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00158	0.00338	CcSEcCtD
Dolasetron—Sepsis—Epirubicin—thyroid cancer	0.00158	0.00338	CcSEcCtD
Dolasetron—Dyspnoea—Sorafenib—thyroid cancer	0.00157	0.00335	CcSEcCtD
Dolasetron—Dyspepsia—Sorafenib—thyroid cancer	0.00155	0.00331	CcSEcCtD
Dolasetron—Phlebitis—Epirubicin—thyroid cancer	0.00154	0.00328	CcSEcCtD
Dolasetron—Decreased appetite—Sorafenib—thyroid cancer	0.00153	0.00327	CcSEcCtD
Dolasetron—Thrombophlebitis—Epirubicin—thyroid cancer	0.00153	0.00327	CcSEcCtD
Dolasetron—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.00152	0.00325	CcSEcCtD
Dolasetron—Fatigue—Sorafenib—thyroid cancer	0.00152	0.00324	CcSEcCtD
Dolasetron—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00152	0.00324	CcSEcCtD
Dolasetron—Pain—Sorafenib—thyroid cancer	0.00151	0.00322	CcSEcCtD
Dolasetron—Constipation—Sorafenib—thyroid cancer	0.00151	0.00322	CcSEcCtD
Dolasetron—Vascular purpura—Epirubicin—thyroid cancer	0.00148	0.00316	CcSEcCtD
Dolasetron—Abnormal vision—Doxorubicin—thyroid cancer	0.00147	0.00314	CcSEcCtD
Dolasetron—Sepsis—Doxorubicin—thyroid cancer	0.00146	0.00313	CcSEcCtD
Dolasetron—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00144	0.00308	CcSEcCtD
Dolasetron—Renal failure acute—Epirubicin—thyroid cancer	0.00143	0.00306	CcSEcCtD
Dolasetron—Phlebitis—Doxorubicin—thyroid cancer	0.00142	0.00304	CcSEcCtD
Dolasetron—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00142	0.00302	CcSEcCtD
Dolasetron—Increased appetite—Epirubicin—thyroid cancer	0.00141	0.00301	CcSEcCtD
Dolasetron—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00141	0.00301	CcSEcCtD
Dolasetron—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.0014	0.00299	CcSEcCtD
Dolasetron—Urticaria—Sorafenib—thyroid cancer	0.0014	0.00299	CcSEcCtD
Dolasetron—Body temperature increased—Sorafenib—thyroid cancer	0.00139	0.00297	CcSEcCtD
Dolasetron—Abdominal pain—Sorafenib—thyroid cancer	0.00139	0.00297	CcSEcCtD
Dolasetron—Purpura—Epirubicin—thyroid cancer	0.00137	0.00293	CcSEcCtD
Dolasetron—Vascular purpura—Doxorubicin—thyroid cancer	0.00137	0.00293	CcSEcCtD
Dolasetron—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00137	0.00292	CcSEcCtD
Dolasetron—Renal failure acute—Doxorubicin—thyroid cancer	0.00133	0.00283	CcSEcCtD
Dolasetron—Increased appetite—Doxorubicin—thyroid cancer	0.0013	0.00279	CcSEcCtD
Dolasetron—Hypersensitivity—Sorafenib—thyroid cancer	0.0013	0.00277	CcSEcCtD
Dolasetron—Face oedema—Epirubicin—thyroid cancer	0.00128	0.00273	CcSEcCtD
Dolasetron—Purpura—Doxorubicin—thyroid cancer	0.00127	0.00272	CcSEcCtD
Dolasetron—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00127	0.0027	CcSEcCtD
Dolasetron—Asthenia—Sorafenib—thyroid cancer	0.00126	0.0027	CcSEcCtD
Dolasetron—Cardiac arrest—Epirubicin—thyroid cancer	0.00126	0.00269	CcSEcCtD
Dolasetron—Pruritus—Sorafenib—thyroid cancer	0.00125	0.00266	CcSEcCtD
Dolasetron—Ataxia—Epirubicin—thyroid cancer	0.00125	0.00266	CcSEcCtD
Dolasetron—Dehydration—Epirubicin—thyroid cancer	0.00123	0.00263	CcSEcCtD
Dolasetron—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00121	0.00258	CcSEcCtD
Dolasetron—Diarrhoea—Sorafenib—thyroid cancer	0.0012	0.00257	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00119	0.00255	CcSEcCtD
Dolasetron—Face oedema—Doxorubicin—thyroid cancer	0.00118	0.00253	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00117	0.00249	CcSEcCtD
Dolasetron—Cardiac arrest—Doxorubicin—thyroid cancer	0.00117	0.00249	CcSEcCtD
Dolasetron—Dizziness—Sorafenib—thyroid cancer	0.00116	0.00249	CcSEcCtD
Dolasetron—Abdominal distension—Epirubicin—thyroid cancer	0.00115	0.00246	CcSEcCtD
Dolasetron—Ataxia—Doxorubicin—thyroid cancer	0.00115	0.00246	CcSEcCtD
Dolasetron—Dehydration—Doxorubicin—thyroid cancer	0.00114	0.00243	CcSEcCtD
Dolasetron—Pancreatitis—Epirubicin—thyroid cancer	0.00112	0.0024	CcSEcCtD
Dolasetron—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00112	0.00239	CcSEcCtD
Dolasetron—Rash—Sorafenib—thyroid cancer	0.00111	0.00237	CcSEcCtD
Dolasetron—Dermatitis—Sorafenib—thyroid cancer	0.00111	0.00237	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.0011	0.00236	CcSEcCtD
Dolasetron—Headache—Sorafenib—thyroid cancer	0.0011	0.00236	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00108	0.00231	CcSEcCtD
Dolasetron—Dysuria—Epirubicin—thyroid cancer	0.00107	0.00229	CcSEcCtD
Dolasetron—Abdominal distension—Doxorubicin—thyroid cancer	0.00107	0.00228	CcSEcCtD
Dolasetron—Pancreatitis—Doxorubicin—thyroid cancer	0.00104	0.00222	CcSEcCtD
Dolasetron—Pneumonia—Epirubicin—thyroid cancer	0.00103	0.00219	CcSEcCtD
Dolasetron—Drowsiness—Epirubicin—thyroid cancer	0.00102	0.00218	CcSEcCtD
Dolasetron—Stomatitis—Epirubicin—thyroid cancer	0.000995	0.00212	CcSEcCtD
Dolasetron—Jaundice—Epirubicin—thyroid cancer	0.000995	0.00212	CcSEcCtD
Dolasetron—Dysuria—Doxorubicin—thyroid cancer	0.00099	0.00211	CcSEcCtD
Dolasetron—Haematuria—Epirubicin—thyroid cancer	0.000973	0.00208	CcSEcCtD
Dolasetron—Epistaxis—Epirubicin—thyroid cancer	0.000963	0.00206	CcSEcCtD
Dolasetron—Pneumonia—Doxorubicin—thyroid cancer	0.00095	0.00203	CcSEcCtD
Dolasetron—Drowsiness—Doxorubicin—thyroid cancer	0.000944	0.00202	CcSEcCtD
Dolasetron—Bradycardia—Epirubicin—thyroid cancer	0.000933	0.00199	CcSEcCtD
Dolasetron—Stomatitis—Doxorubicin—thyroid cancer	0.00092	0.00197	CcSEcCtD
Dolasetron—Jaundice—Doxorubicin—thyroid cancer	0.00092	0.00197	CcSEcCtD
Dolasetron—Oedema peripheral—Epirubicin—thyroid cancer	0.000902	0.00193	CcSEcCtD
Dolasetron—Haematuria—Doxorubicin—thyroid cancer	0.0009	0.00192	CcSEcCtD
Dolasetron—Epistaxis—Doxorubicin—thyroid cancer	0.000891	0.0019	CcSEcCtD
Dolasetron—Visual impairment—Epirubicin—thyroid cancer	0.000883	0.00189	CcSEcCtD
Dolasetron—Bradycardia—Doxorubicin—thyroid cancer	0.000863	0.00184	CcSEcCtD
Dolasetron—Tinnitus—Epirubicin—thyroid cancer	0.000854	0.00182	CcSEcCtD
Dolasetron—Flushing—Epirubicin—thyroid cancer	0.00085	0.00182	CcSEcCtD
Dolasetron—Oedema peripheral—Doxorubicin—thyroid cancer	0.000835	0.00178	CcSEcCtD
Dolasetron—Chills—Epirubicin—thyroid cancer	0.000822	0.00176	CcSEcCtD
Dolasetron—Arrhythmia—Epirubicin—thyroid cancer	0.000818	0.00175	CcSEcCtD
Dolasetron—Visual impairment—Doxorubicin—thyroid cancer	0.000817	0.00174	CcSEcCtD
Dolasetron—Tinnitus—Doxorubicin—thyroid cancer	0.00079	0.00169	CcSEcCtD
Dolasetron—Flushing—Doxorubicin—thyroid cancer	0.000787	0.00168	CcSEcCtD
Dolasetron—Flatulence—Epirubicin—thyroid cancer	0.000786	0.00168	CcSEcCtD
Dolasetron—Dysgeusia—Epirubicin—thyroid cancer	0.000781	0.00167	CcSEcCtD
Dolasetron—Chills—Doxorubicin—thyroid cancer	0.000761	0.00162	CcSEcCtD
Dolasetron—Arrhythmia—Doxorubicin—thyroid cancer	0.000757	0.00162	CcSEcCtD
Dolasetron—Ill-defined disorder—Epirubicin—thyroid cancer	0.00074	0.00158	CcSEcCtD
Dolasetron—Anaemia—Epirubicin—thyroid cancer	0.000737	0.00157	CcSEcCtD
Dolasetron—Agitation—Epirubicin—thyroid cancer	0.000733	0.00157	CcSEcCtD
Dolasetron—Flatulence—Doxorubicin—thyroid cancer	0.000727	0.00155	CcSEcCtD
Dolasetron—Dysgeusia—Doxorubicin—thyroid cancer	0.000723	0.00154	CcSEcCtD
Dolasetron—Malaise—Epirubicin—thyroid cancer	0.000719	0.00154	CcSEcCtD
Dolasetron—Vertigo—Epirubicin—thyroid cancer	0.000716	0.00153	CcSEcCtD
Dolasetron—Syncope—Epirubicin—thyroid cancer	0.000715	0.00153	CcSEcCtD
Dolasetron—Palpitations—Epirubicin—thyroid cancer	0.000705	0.00151	CcSEcCtD
Dolasetron—Loss of consciousness—Epirubicin—thyroid cancer	0.000701	0.0015	CcSEcCtD
Dolasetron—Cough—Epirubicin—thyroid cancer	0.000696	0.00149	CcSEcCtD
Dolasetron—Convulsion—Epirubicin—thyroid cancer	0.000691	0.00148	CcSEcCtD
Dolasetron—Hypertension—Epirubicin—thyroid cancer	0.000689	0.00147	CcSEcCtD
Dolasetron—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000685	0.00146	CcSEcCtD
Dolasetron—Anaemia—Doxorubicin—thyroid cancer	0.000682	0.00146	CcSEcCtD
Dolasetron—Myalgia—Epirubicin—thyroid cancer	0.000679	0.00145	CcSEcCtD
Dolasetron—Arthralgia—Epirubicin—thyroid cancer	0.000679	0.00145	CcSEcCtD
Dolasetron—Chest pain—Epirubicin—thyroid cancer	0.000679	0.00145	CcSEcCtD
Dolasetron—Agitation—Doxorubicin—thyroid cancer	0.000678	0.00145	CcSEcCtD
Dolasetron—Anxiety—Epirubicin—thyroid cancer	0.000677	0.00145	CcSEcCtD
Dolasetron—Discomfort—Epirubicin—thyroid cancer	0.000671	0.00143	CcSEcCtD
Dolasetron—Malaise—Doxorubicin—thyroid cancer	0.000665	0.00142	CcSEcCtD
Dolasetron—Dry mouth—Epirubicin—thyroid cancer	0.000664	0.00142	CcSEcCtD
Dolasetron—Vertigo—Doxorubicin—thyroid cancer	0.000663	0.00142	CcSEcCtD
Dolasetron—Syncope—Doxorubicin—thyroid cancer	0.000662	0.00141	CcSEcCtD
Dolasetron—Confusional state—Epirubicin—thyroid cancer	0.000656	0.0014	CcSEcCtD
Dolasetron—Palpitations—Doxorubicin—thyroid cancer	0.000652	0.00139	CcSEcCtD
Dolasetron—Oedema—Epirubicin—thyroid cancer	0.000651	0.00139	CcSEcCtD
Dolasetron—Anaphylactic shock—Epirubicin—thyroid cancer	0.000651	0.00139	CcSEcCtD
Dolasetron—Loss of consciousness—Doxorubicin—thyroid cancer	0.000649	0.00139	CcSEcCtD
Dolasetron—Cough—Doxorubicin—thyroid cancer	0.000644	0.00138	CcSEcCtD
Dolasetron—Shock—Epirubicin—thyroid cancer	0.00064	0.00137	CcSEcCtD
Dolasetron—Convulsion—Doxorubicin—thyroid cancer	0.000639	0.00137	CcSEcCtD
Dolasetron—Thrombocytopenia—Epirubicin—thyroid cancer	0.000637	0.00136	CcSEcCtD
Dolasetron—Hypertension—Doxorubicin—thyroid cancer	0.000637	0.00136	CcSEcCtD
Dolasetron—Tachycardia—Epirubicin—thyroid cancer	0.000635	0.00136	CcSEcCtD
Dolasetron—Hyperhidrosis—Epirubicin—thyroid cancer	0.000629	0.00134	CcSEcCtD
Dolasetron—Myalgia—Doxorubicin—thyroid cancer	0.000628	0.00134	CcSEcCtD
Dolasetron—Chest pain—Doxorubicin—thyroid cancer	0.000628	0.00134	CcSEcCtD
Dolasetron—Arthralgia—Doxorubicin—thyroid cancer	0.000628	0.00134	CcSEcCtD
Dolasetron—Anxiety—Doxorubicin—thyroid cancer	0.000626	0.00134	CcSEcCtD
Dolasetron—Discomfort—Doxorubicin—thyroid cancer	0.000621	0.00133	CcSEcCtD
Dolasetron—Anorexia—Epirubicin—thyroid cancer	0.00062	0.00133	CcSEcCtD
Dolasetron—Dry mouth—Doxorubicin—thyroid cancer	0.000614	0.00131	CcSEcCtD
Dolasetron—Hypotension—Epirubicin—thyroid cancer	0.000608	0.0013	CcSEcCtD
Dolasetron—Confusional state—Doxorubicin—thyroid cancer	0.000607	0.0013	CcSEcCtD
Dolasetron—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000602	0.00129	CcSEcCtD
Dolasetron—Oedema—Doxorubicin—thyroid cancer	0.000602	0.00129	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000593	0.00127	CcSEcCtD
Dolasetron—Shock—Doxorubicin—thyroid cancer	0.000592	0.00127	CcSEcCtD
Dolasetron—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00059	0.00126	CcSEcCtD
Dolasetron—Tachycardia—Doxorubicin—thyroid cancer	0.000588	0.00126	CcSEcCtD
Dolasetron—Paraesthesia—Epirubicin—thyroid cancer	0.000584	0.00125	CcSEcCtD
Dolasetron—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000582	0.00124	CcSEcCtD
Dolasetron—Dyspnoea—Epirubicin—thyroid cancer	0.00058	0.00124	CcSEcCtD
Dolasetron—Somnolence—Epirubicin—thyroid cancer	0.000579	0.00124	CcSEcCtD
Dolasetron—Anorexia—Doxorubicin—thyroid cancer	0.000574	0.00123	CcSEcCtD
Dolasetron—Dyspepsia—Epirubicin—thyroid cancer	0.000573	0.00122	CcSEcCtD
Dolasetron—Decreased appetite—Epirubicin—thyroid cancer	0.000566	0.00121	CcSEcCtD
Dolasetron—Hypotension—Doxorubicin—thyroid cancer	0.000563	0.0012	CcSEcCtD
Dolasetron—Fatigue—Epirubicin—thyroid cancer	0.000561	0.0012	CcSEcCtD
Dolasetron—Pain—Epirubicin—thyroid cancer	0.000557	0.00119	CcSEcCtD
Dolasetron—Constipation—Epirubicin—thyroid cancer	0.000557	0.00119	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000549	0.00117	CcSEcCtD
Dolasetron—Paraesthesia—Doxorubicin—thyroid cancer	0.000541	0.00115	CcSEcCtD
Dolasetron—Dyspnoea—Doxorubicin—thyroid cancer	0.000537	0.00115	CcSEcCtD
Dolasetron—Feeling abnormal—Epirubicin—thyroid cancer	0.000536	0.00115	CcSEcCtD
Dolasetron—Somnolence—Doxorubicin—thyroid cancer	0.000535	0.00114	CcSEcCtD
Dolasetron—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000532	0.00114	CcSEcCtD
Dolasetron—Dyspepsia—Doxorubicin—thyroid cancer	0.00053	0.00113	CcSEcCtD
Dolasetron—Decreased appetite—Doxorubicin—thyroid cancer	0.000524	0.00112	CcSEcCtD
Dolasetron—Fatigue—Doxorubicin—thyroid cancer	0.000519	0.00111	CcSEcCtD
Dolasetron—Urticaria—Epirubicin—thyroid cancer	0.000517	0.0011	CcSEcCtD
Dolasetron—Constipation—Doxorubicin—thyroid cancer	0.000515	0.0011	CcSEcCtD
Dolasetron—Pain—Doxorubicin—thyroid cancer	0.000515	0.0011	CcSEcCtD
Dolasetron—Abdominal pain—Epirubicin—thyroid cancer	0.000515	0.0011	CcSEcCtD
Dolasetron—Body temperature increased—Epirubicin—thyroid cancer	0.000515	0.0011	CcSEcCtD
Dolasetron—Feeling abnormal—Doxorubicin—thyroid cancer	0.000496	0.00106	CcSEcCtD
Dolasetron—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000492	0.00105	CcSEcCtD
Dolasetron—Hypersensitivity—Epirubicin—thyroid cancer	0.00048	0.00102	CcSEcCtD
Dolasetron—Urticaria—Doxorubicin—thyroid cancer	0.000478	0.00102	CcSEcCtD
Dolasetron—Abdominal pain—Doxorubicin—thyroid cancer	0.000476	0.00102	CcSEcCtD
Dolasetron—Body temperature increased—Doxorubicin—thyroid cancer	0.000476	0.00102	CcSEcCtD
Dolasetron—Asthenia—Epirubicin—thyroid cancer	0.000467	0.000997	CcSEcCtD
Dolasetron—Pruritus—Epirubicin—thyroid cancer	0.00046	0.000983	CcSEcCtD
Dolasetron—Diarrhoea—Epirubicin—thyroid cancer	0.000445	0.000951	CcSEcCtD
Dolasetron—Hypersensitivity—Doxorubicin—thyroid cancer	0.000444	0.000948	CcSEcCtD
Dolasetron—Asthenia—Doxorubicin—thyroid cancer	0.000432	0.000923	CcSEcCtD
Dolasetron—Dizziness—Epirubicin—thyroid cancer	0.00043	0.000919	CcSEcCtD
Dolasetron—Pruritus—Doxorubicin—thyroid cancer	0.000426	0.00091	CcSEcCtD
Dolasetron—Diarrhoea—Doxorubicin—thyroid cancer	0.000412	0.00088	CcSEcCtD
Dolasetron—Rash—Epirubicin—thyroid cancer	0.00041	0.000876	CcSEcCtD
Dolasetron—Dermatitis—Epirubicin—thyroid cancer	0.00041	0.000876	CcSEcCtD
Dolasetron—Headache—Epirubicin—thyroid cancer	0.000408	0.000871	CcSEcCtD
Dolasetron—Dizziness—Doxorubicin—thyroid cancer	0.000398	0.000851	CcSEcCtD
Dolasetron—Rash—Doxorubicin—thyroid cancer	0.00038	0.000811	CcSEcCtD
Dolasetron—Dermatitis—Doxorubicin—thyroid cancer	0.000379	0.00081	CcSEcCtD
Dolasetron—Headache—Doxorubicin—thyroid cancer	0.000377	0.000806	CcSEcCtD
